Ankur Naqib

Dr. Ankur Naqib

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
FBFaraz Bishehsari
Faraz Bishehsari
PEPhillip A. Engen
Phillip A. Engen
RVRobin M. Voigt
Robin M. Voigt
GSGarth Swanson
Garth Swanson
MSMaliha Shaikh
Maliha Shaikh
KKKhashayarsha Khazaie
Khashayarsha Khazaie
Alcohol intake with circadian rhythm disruption (CRD) increases colon cancer risk. We hypothesized that eating during or around physiologic rest time, a common habit in modern society, causes CRD and investigated the mechanisms by which it promotes alcohol-associated colon carcinogenesis. The effect of feeding time on CRD was assessed using B6 mice expressing a fusion protein of PERIOD2 and LUCIFERASE (PER2::LUC) were used to model colon polyposis and to assess the effects of feeding schedules, alcohol consumption, and prebiotic treatment on microbiota composition, short-chain fatty acid levels, colon inflammation, and cancer risk. The relationship between butyrate signaling and a proinflammatory profile was assessed by inactivating the butyrate receptor GPR109A. Eating at rest (wrong-time eating [WTE]) shifted the phase of the colon rhythm in PER2::LUC mice. In TS4Cre × APClox468 mice, a combination of WTE and alcohol exposure (WTE + alcohol) decreased the levels of short-chain fatty acid-producing bacteria and of butyrate, reduced colonic densities of regulatory T cells, induced a proinflammatory profile characterized by hyperpermeability and an increased mucosal T-helper cell 17/regulatory T cell ratio, and promoted colorectal cancer. Prebiotic treatment improved the mucosal inflammatory profile and attenuated inflammation and cancer. WTE + alcohol-induced polyposis was associated with increased signal transducer and activator of transcription 3 expression. Decreased butyrate signaling activated the epithelial signal transducer and activator of transcription 3 in vitro. The relationship between butyrate signaling and a proinflammatory profile was confirmed in human colorectal cancers using The Cancer Genome Atlas. Abnormal timing of food intake caused CRD and interacts with alcohol consumption to promote colon carcinogenesis by inducing a protumorigenic inflammatory profile driven by changes in the colon microbiota and butyrate signaling. Accession number of repository for microbiota sequence data: raw FASTQ data were deposited in the NCBI Sequence Read Archive under project PRJNA523141.

20 December 2019 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
JWJuan Maldonado Weng
Juan Maldonado Weng
IPIshita Parikh
Ishita Parikh
ANAnkur Naqib
Ankur Naqib
JYJason York
Jason York
SGStefan J. Green
Stefan J. Green
MLMary Jo LaDu
Mary Jo LaDu
Background: Alzheimer’s disease (AD) is a fatal neurodegenerative disease.APOE4is the greatest genetic risk factor for AD, increasing risk up to 15-fold compared to the commonAPOE3.Importantly, female (♀)APOE4carriers have a greater risk for developing AD and an increased rate of cognitive decline compared to male (♂)APOE4carriers. While recent evidence demonstrates that AD,APOEgenotype, and sex affect the gut microbiome (GM), howAPOEgenotype and sex interact to affect the GM in AD remains unknown.Methods: This study analyzes the GM of 4-month (4 M) ♂ and ♀ E3FAD and E4FAD mice, transgenic mice that overproduce amyloid-β 42 (Aβ42) and express humanAPOE3+/+orAPOE4+/+. Fecal microbiotas were analyzed using high-throughput sequencing of 16S ribosomal RNA gene amplicons and clustered into operational taxonomic units (OTU). Microbial diversity of the EFAD GM was compared acrossAPOE,sex and stratified byAPOE + sex, resulting in 4-cohorts (♂E3FAD, ♀E3FAD, ♂E4FAD and ♀E4FAD). Permutational multivariate analysis of variance (PERMANOVA) evaluated differences in bacterial communities between cohorts and the effects ofAPOE + sex. Mann-Whitney tests and machine-learning algorithms identified differentially abundant taxa associated withAPOE + sex.Results: Significant differences in the EFAD GM were associated withAPOEgenotype and sex. Stratification byAPOE + sex revealed thatAPOE-associated differences were exhibited in ♂EFAD and ♀EFAD mice, and sex-associated differences were exhibited in E3FAD and E4FAD mice. Specifically, the relative abundance of bacteria from the generaPrevotellaandRuminococcuswas significantly higher in ♀E4FAD compared to ♀E3FAD, while the relative abundance ofSutterellawas significantly higher in ♂E4FAD compared to ♂E3FAD. Based on 29 OTUs identified by the machine-learning algorithms, heatmap analysis revealed significant clustering of ♀E4FAD separate from other cohorts.Conclusions: The results demonstrate that the 4 M EFAD GM is modulated byAPOE + sex. Importantly, the effect ofAPOE4on the EFAD GM is modulated by sex, a pattern similar to the greater AD pathology associated with ♀E4FAD. While this study demonstrates the importance of interactive effects ofAPOE + sex on the GM in young AD transgenic mice, changes associated with the development of pathology remain to be defined.

24 July 2020 in Neurobiology of Disease
Verified
Journal Article
Open access
VJValerie Joers
Valerie Joers
GMGunasingh Masilamoni
Gunasingh Masilamoni
DKDoty Kempf
Doty Kempf
AWAlison R. Weiss
Alison R. Weiss
TRTravis M. Rotterman
Travis M. Rotterman
MTMalú G. Tansey
Malú G. Tansey
Inflammation has been linked to the development of nonmotor symptoms in Parkinson’s disease (PD), which greatly impact patients’ quality of life and can often precede motor symptoms. Suitable animal models are critical for our understanding of the mechanisms underlying disease and the associated prodromal disturbances. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkey model is commonly seen as a “gold standard” model that closely mimics the clinical motor symptoms and the nigrostriatal dopaminergic loss of PD, however MPTP toxicity extends to other nondopaminergic regions. Yet, there are limited reports monitoring the MPTP-induced progressive central and peripheral inflammation as well as other nonmotor symptoms such as gastrointestinal function and microbiota. We report 5 cases of progressive parkinsonism in non-human primates to gain a broader understanding of MPTP-induced central and peripheral inflammatory dysfunction to understand the potential role of inflammation in prodromal/pre-motor features of PD-like degeneration. We measured inflammatory proteins in plasma and CSF and performed [18F]FEPPA PET scans to evaluate translocator proteins (TSPO) or microglial activation. Monkeys were also evaluated for working memory and executive function using various behavior tasks and for gastrointestinal hyperpermeability and microbiota composition. Additionally, monkeys were treated with a novel TNF inhibitor XPro1595 (10mg/kg, n=3) or vehicle (n=2) every three days starting 11 weeks after the initiation of MPTP to determine whether XPro1595 would alter inflammation and microglial behavior in a progressive model of PD. The case studies revealed that earlier and robust [18F]FEPPA PET signals resulted in earlier and more severe parkinsonism, which was seen in male cases compared to female cases. Potential other sex differences were observed in circulating inflammation, microbiota diversity and their metabolites. Additional studies with larger group sizes of both sexes would enable confirmation and extension of these findings. If these findings reflect potential differences in humans, these sex differences have significant implications for therapeutic development of inflammatory targets in the clinic.

24 September 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
LLLisa M. Lamothe
Lisa M. Lamothe
TCThaisa Cantu-Jungles
Thaisa Cantu-Jungles
TCTingting Chen
Tingting Chen
SGStefan Green
Stefan Green
ANAnkur Naqib
Ankur Naqib
BHBruce Hamaker
Bruce Hamaker
Insoluble dietary fibers are typically known to be poorly fermented in the large intestine. However, their value may be high as evidence shows that important butyrogenic bacteria preferentially utilize insoluble substrates to support their energy needs. The objective of this study was to increase fermentability of an insoluble bran fiber (pearl millet) while keeping it mostly insoluble to promote bacteria in the community that rely on fermentable insoluble dietary fibers. Following pretests with different processing methods, a combination of microwave and enzymatic treatments were applied to isolated pearl millet fiber to increase its accessibility of gut bacteria. In vitro human fecal fermentation was conducted and analyses were made for short chain fatty acids and microbiota changes. Combined microwave and enzymatic processing increased the amount of insoluble fiber fermented in vitro from 36 to 59% of total dietary fiber, with a minor increase in soluble fiber (8%). Microwave/enzymatic processing doubled butyrate production and almost tripled acetate production at 6 h fermentation compared to the native millet fiber. 16S rRNA gene sequencing showed that the processing promoted a significant increase in Firmicutes/Bacteroidetes ratio compared to the native fiber with relative abundance increases in Blautia and Copprococcus genera and a decrease in Bacteroidetes. Overall, these data show that processing techniques can be used to increase the value of insoluble fiber, presumably by increasing accessibility of the fiber to degrading bacteria, and to support Firmicutes that preferentially compete on insoluble fibers.

3 December 2021 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
SCSarah Chellappa
Sarah Chellappa
PEPhillip A Engen
Phillip A Engen
ANAnkur Naqib
Ankur Naqib
JQJingyi Qian
Jingyi Qian
NVNina Vujovic
Nina Vujovic
FSFrank A.J.L. Scheer
Frank A.J.L. Scheer

23 June 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAndrew Armstrong
Andrew Armstrong
MHMuhammad R. Haque
Muhammad R. Haque
SMSina Mirbagheri
Sina Mirbagheri
UBUsman Barlass
Usman Barlass
DGDouglas Z. Gilbert
Douglas Z. Gilbert
FBFaraz Bishehsari
Faraz Bishehsari
Pancreatic ductal adenocarcinoma (PDA) is an extremely lethal malignancy arising from the pancreas. The treatment of PDA is complicated by ineffective treatments and a lack of biomarkers predictive of treatment success. We have designed a patient-derived organoid (PDO) based high-throughput drug screening assay to model treatment response to a variety of conventional and investigational treatments for PDA. Consecutive patients undergoing endoscopic ultrasound-guided fine-needle biopsy for tissue diagnosis of PDA at Rush University Medical Center were offered to participate in the study. Biopsies were immediately processed to develop organoids. Fifteen PDOs were screened for sensitivity to 18 compounds, including conventional PDA chemotherapies and FDA-approved investigational targeted therapies in cancer using Cell-titer GLO 3D (Promega) cell viability assay. The area under the curve (AUC) was calculated and normalized to the maximum area under the curve to generate a normalized AUC between 0 and 1. Molecular profiling of PDOs was conducted using RNA-seq. Human PDA transcriptomic was extracted from The Cancer Genome Atlas (TCGA). The drug response curves were reproducible. We observed variation in response to conventional therapies overall as well as among individual patients. There were distinct transcriptome signatures associated with response to the conventional chemotherapeutics in PDA. The transcriptomic profile of overall resistance to conventional therapies in our study was associated with poor survival in PDA patients in TCGA. Our pathway analysis for targeted drugs revealed a number of predictors of response associated with the mechanism of action of the tested drug. The multiplex organoid-based drug assay could be used in preclinical to inform patient stratification and therapeutic selection in PDA. When combined with omics data, ex vivo response to treatment could help identify gene signatures associated with response to novel therapies.